0001485003-16-000185.txt : 20160928
0001485003-16-000185.hdr.sgml : 20160928
20160928161400
ACCESSION NUMBER: 0001485003-16-000185
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160920
FILED AS OF DATE: 20160928
DATE AS OF CHANGE: 20160928
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001485003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 252025616
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-9911
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Clairmark Investments Ltd.
CENTRAL INDEX KEY: 0001652078
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36296
FILM NUMBER: 161907093
BUSINESS ADDRESS:
STREET 1: 305 MILNER AVENUE, SUITE 914
CITY: TORONTO
STATE: A6
ZIP: M1B3V4
BUSINESS PHONE: 416-940-6995
MAIL ADDRESS:
STREET 1: 305 MILNER AVENUE, SUITE 914
CITY: TORONTO
STATE: A6
ZIP: M1B3V4
3
1
wf-form3_147509362699302.xml
FORM 3
X0206
3
2016-09-20
0
0001485003
Eleven Biotherapeutics, Inc.
EBIO
0001652078
Clairmark Investments Ltd.
C/O ELEVEN BIOTHERAPEUTICS, INC.
215 FIRST STREET, SUITE 400
CAMBRIDGE
MA
02142
0
0
1
0
Common Stock
3582328
D
The reporting person acquired 3,582,328 shares of issuer common stock in exchange for an 89.2585% interest in Viventia Bio, Inc. pursuant to the issuer's purchase of all outstanding capital stock of Viventia Bio Inc. on September 20, 2016. Of the 3,582,328 shares issued to the reporting person in the transaction 358,232 shares re currently being held in escrow and are subject to forfeiture during the 15-month period following the transaction to satisfy claims arising as a result of Viventia Bio Inc.'s or the reporting person's breach of any of their respective representations, warranties or covenants in the share purchase agreement.
CLAIRMARK INVESTMENTS LTD. /s/ Leslie L. Dan, President
2016-09-22